The hazard
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20.
- Brand / company
- Fresenius Kabi USA, LLC
- Codes / lots
- Lot: 16UI07, Exp 08/31/2028
- Distribution
- Nationwide in the USA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 2 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.